Sleep

Results show ISR is a promising behavioral treatment for insomnia, which can reduce sleep latency, increase total sleep time as well as sleep efficiency, and may serve as an alternative to traditional treatments.

The cross-sectional analysis found a significant association between greater insomnia severity and worsened quality of life, decreased productivity, and increased healthcare resource utilization.

A new study has found individuals with depression and insomnia show significantly less activity in the prefrontal cortex during verbal fluency tests, suggesting that sleep quality is an important indicator in fNIRS screening.

Results reveal changes in sleep problems across adolescence are associated with internalizing and externalizing symptoms, highlighting the need to address this early.

New data demonstrate suvorexant and lemborexant were equally effective in improving sleep status, but lemborexant may cause side effects less frequently.

The petition with the US DEA is aiming to remove dual orexin receptor antagonist medications from the Controlled Substances Act due to negligible potential for abuse.

Investigators found girls with depression and anxiety responded especially well to melatonin treatment, suggesting the potential of sleep interventions in reducing the risk of self-harm.

Digital Cognitive Behavior Therapy for Insomnia (CBT-I) is equally effective in treating insomnia in individuals with or without co-occurring chronic fatigue, according to a recent study.

The first study to examine joint effects of physical activity and sleep duration on mortality risk using accelerometry, results indicate increase activity could negate the effects of short or long sleep duration on cardiovascular and all-cause mortality.

As little as 39 minutes less sleep per night for 1 week can have an impact on the quality of life of children.

A multinational study provides new insight into the impact of suboptimal sleep duration on risk of incident peripheral artery disease.

Results shows female adolescents are more likely to transition into and out of insulin resistance, whereas adolescent males are more consistently normal.

This endocrine case report features a patient in their mid-50s with a history of recent TIA presenting to the hospital with increasing anxiety and insomnia over the past week. Can you determine the correct diagnosis?

According to the data, sleep quality, fatigue, and social well-being contribute to depression among young adults with autism, with social well-being being a significant predictor of depression over a 2-year period.

An analysis of actigraphy data obtained from the MESA Sleep Ancillary Study indicates irregularities in sleep patterns, particularly in duration and timing of sleep, were linked to increased markers of subclinical atherosclerosis, including increased coronary artery calcium burden.

Patients with with depression and AHI ≥ 30 show the greatest risk of all-cause mortality.

Based on data from the systematic review, investigators urge for the prioritization of sleep as a core clinical target and further investigation across the stages of psychosis.

Dr. Neomi Shah explains why improving access to behavioral care for insomnia needs to be prioritized.

The study evaluated how intranasal mometasone furoate affected sleep-disordered breathing symptoms and patient quality of life by comparing its efficacy to intranasal saline in the pediatric patients.

Those who were assigned female at birth, had worse physical health, and self-reported symptoms of anxiety, were vulnerable to poor sleep quality in all aspects.

Sleep and epilepsy have been described as "unfortunate bedfellows" due to the complex relationship, and yet caretakers report a lack of support managing these issues commonly experienced by children.

Based on the identified biomarkers, it was possible to distinguish patients with a good predictive value for pain, sleep, and anxiety.

The potential mediating role of inflammation at 9 years, measured by CRP and IL-6, was investigated in the relationship between sleep and ADHD.

The daytime-nighttime appliance named DNA, serves as a novel alternative to existing treatment options for mild-to-moderate obstructive sleep apnea.

Results indicated similar outcomes between those who underwent tonsillectomy and mUPPP, with minor differences favoring the tonsillectomy group.